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Formation of -Hydroxy Histidine
in the Biosynthesis of Nikkomycin Antibiotics
isolated and heterologously expressed in Streptomyces
lividans to produce all of the nikkomycins [7]. The ongo-
ing sequencing of the nik cluster and systematic analysis
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chemical characterizations, have led to the proposal ofHarvard Medical School
a biosynthetic pathway for the first amino acid residue240 Longwood Avenue
HPHT [8, 9].Boston, Massachusetts 02115
Although L-His was shown to be the precursor of the
imidazolone base, insight into the formation of the base
from histidine was only obtained recently when a geneSummary
encoding a heme-dependent protein (NikQ) was dis-
rupted and shown to be involved in imidazolone biosyn-
Nikkomycins, a group of peptidyl nucleoside antibiot-
thesis, probably by -hydroxylating L-His [10]. NikQ is
ics produced Streptomyces tendae Tu¨901, are potent similar to a distinct subgroup of the heme-dependent
competitive inhibitors of chitin synthase. In this study, enzyme family that includes ORF20 of the chloroeremo-
three nikkomycin biosynthetic enzymes, NikP1, NikQ, mycin cluster [11], NovI of the novobiocin cluster [12],
and NikP2, were overexpressed, purified, and charac- CumD of the coumermycin A1 cluster [13], and SimI of theterized. The NikP1 activated L-His and transferred it simocyclinone cluster (direct deposit to the databank by
to the carrier protein domain to form L-His-S-NikP1, L. Heide, accession number AF321122). NovI has been
which served as the-hydroxylation substrate of NikQ. established to be a -hydroxylase specific for L-Tyr co-
The -OH-His was then hydrolytically released from valently tethered to the phosphopantetheine (Ppant)
NikP1 by NikP2. The results reported here substantiate prosthetic group of the peptidyl carrier protein (PCP)
our earlier proposal that the covalent tethering of an domain of the partner protein NovH [14]. NovH resem-
amino acid onto a carrier protein domain prior to bles a typical nonribosomal peptide synthetase (NRPS)
downstream modification is a general strategy for di- with two domains, an L-Tyr specific adenylation (A) do-
verting a fraction of the amino acid into secondary main and a PCP domain [15, 16]. Free L-tyrosine and the
metabolism. small molecule mimic of aminoacyl-S-enzyme, L-Tyr-
S-(N-acetyl)cysteamine thioester (L-Tyr-S-NAC), failed
to be recognized and processed by NovI [14]. All ofIntroduction
these factors prompted us to look for a potential dido-
main NRPS partner protein that may function with NikQNikkomycins, a group of peptidyl nucleoside antibiotics
in the -hydroxylation of L-His. Indeed, examination ofproduced by Streptomyces tendae Tu¨901, are potent
the nik cluster in a surrounding region of nikQ quicklycompetitive inhibitors of chitin synthase [1–3]. These
revealed the nikP1 gene (Figure 2A), which encodesantibiotics are structurally similar to the chitin synthase
an A-PCP NRPS didomain [17]. Interestingly, there is asubstrate UDP-N-acetylglucosamine and show high
thioesterase (TE) gene, nikP2, flanked by the nikP1 andfungicidal, insecticidal, and acaricidal activity [1–3]. Nik-
nikQ genes, that encodes a protein which is similar to thekomycin X, a dipeptidyl nucleoside natural product iso-
free-standing type II TEs found in polyketide synthaselated as a major component from the culture filtrate of
(PKS) and NRPS clusters. We surmised that, analogousS. tendae Tu¨901, contains two unusual amino acids,
to the NovH and NovI pair, NikP1 and NikQ may functionhydroxypyridylhomothreonine (HPHT) and aminohexur-
in concert to carry out L-His -hydroxylation to give theonic acid with an N-glycosidically linked 4-formyl-4-imi-
-OH-His-S-NikP1 intermediate. Subsequent hydrolysisdazolin-2-one (imidazolone) base (Figure 1). The other
by NikP2 would release free -OH-His (Figure 2B). Fur-major component, nikkomycin Z, has a similar molecular
ther oxygenation on the imidazole ring and cleavage ofstructure to nikkomycin X, but the imidazolone base is
the two-carbon unit (glycine) will lead to the desiredreplaced with uracil (Figure 1). Minor components of the
imidazolone base found in nikkomycins X/I. Here weculture filtrate are nikkomycins I/J, tripeptide antibiotics
report the biochemical characterizations of three puri-containing an additional C-terminal glutamate to the nik-
fied enzymes, NikP1, NikQ, and NikP2, for their role in thekomycin X/Z, respectively (Figure 1). The aminohexuro-
biosynthesis of -OH-His. The results presented here
nic acid derivatives isolated from some mutant strains
reinforce our recent proposal that the A domain of a
are designated as nikkomycins CX/CZ (Figure 1). didomain NRPS can be used to divert a fraction of the
Early radiolabeled precursor feeding experiments es- amino acid pool for -hydroxylation and further pro-
tablished that the pyridyl residue in HPHT originates cessing to a secondary metabolite [14].
from L-lysine and that L-His is the precursor of the imida-
zolone base [4]. The biogenesis of the aminohexuronic Results
acid moiety is believed to be similar to that of the polyox-
ins, in which a ribose sugar is condensed with phospho- Expression, Purification, and Initial Characterization
enolpyruvate (PEP) [5, 6]. The entire nik cluster has been of NikP1, NikQ, and NikP2
All three genes were individually amplified from the ge-
nomic DNA of S. tendae Tu¨901 by PCR and cloned into2 Correspondence: christopher_walsh@hms.harvard.edu
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Figure 1. Chemical Structures of the Nikko-
mycin Antibiotics with Bases Highlighted in Red
appropriate pET vectors for protein expression in E. coli. ure 3A). NikP1 was also coexpressed with Sfp, a phos-
phopantetheinyl-transferase (PPTase) from BacillusImproved soluble protein yield (70 mg/L) of NikP1was
obtained by lowering the expression temperature to subtilis [18], and purified similarly. NikQ was isolated
fully loaded with heme cofactor when grown at 15C for24C after induction with isopropyl -D-thiogalactoside
(IPTG). NikP1 was purified to near homogeneity in a 72 hr without the addition of IPTG. Including FeCl3 and
-aminolevulinic acid in the culture medium was essen-single step by nickel-NTA affinity chromatography (Fig-
Figure 2. Biosynthesis of -OH-His Found in Nikkomycins
(A) The partial nikkomycin biosynthetic gene cluster and three genes that are involved in -OH-His biogenesis are highlighted in red.
(B) Proposed functions of NikP1, NikQ, and NikP2 in the biosynthesis of -OH-His. The function of the N-terminal MbtH-like domain (designated
as X) is not clear. The PCP domain in NikP1 can be primed by a PPTase to install the 4-phosphopantetheine (Ppant) prosthetic group with
free CoA. The A domain activates and loads L-His onto the free thiol of the prosthetic arm to generate L-His-S-NikP1 aminoacyl-S-enzyme.
The -hydroxylation reaction is effected by the heme-associated monooxygenase NikQ when molecular oxygen and external electrons are
provided. Finally, -OH-His is released from the PCP domain by a type II TE NikP2. Further transformations will afford the imidazolone base
found in nikkomycins X/I.
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Figure 3. Purification of Nik Proteins
(A) Coomassie brilliant blue-stained 5%–15% SDS-PAGE gradient gel showing isolated NikP1, NikQ, and NikP2 proteins from E. coli.
(B) The UV-visible spectrum of the purified NikQ protein containing one equivalent of heme cofactor.
tial to obtain holo heme protein (Figure 3B). Unlike the all ten signature sequences (A1–A10) [16], but the poten-
tial substrate remained unclear even after a carefulcases of NikP1 and NikQ, initial attempts to produce
comparison with A domains of known specificity in thesoluble NikP2 protein failed when the nikP2 gene was
data bank. The amino acid code of the NikP1 A domainexpressed from the pET16b vector alone. Inspection of
(DAESIAVITK) is significantly different from the onlythe nik cluster revealed that the nikP2 and nikQ are
known L-His-specific A domain in BacC (DSEATAEVCK)cotranscribed genes overlapping by 11 bases. The solu-
involved in bacitracin biosynthesis [19, 20]. The otherbility of NikP2 protein in E. coli was much improved
putative L-His-specific A domain (DSAAIAEVWK) lies inwhen nikQ and nikP2 genes were expressed together
NRPS8 of the bleomycin cluster [21], but it is possiblefrom the pET16b vector. Production of both proteins
that -OH-His is the native substrate for that A domain.was observed by SDS-PAGE, and NikP2 was readily
To determine the substrate specificity of the NikP1 Aisolated by nickel affinity chromatography when a His10
domain and see if the NikP1 A domain specifically acti-tag was specifically installed on the NikP2 N terminus.
vates L-His using ATP as a cosubstrate, the classical
ATP-pyrophosphate (PPi) exchange assay was used toCharacterization of NikP1 as an L-His-Specific
monitor the reversible incorporation of [32P]PPi into ATPDidomain NRPS for L-Histidinyl-S-NikP1
in a substrate-dependent fashion [22]. Of all the commonAminoacyl Enzyme Formation
amino acids screened, L-His showed the highest activ-Translated nikP1 has 667 amino acid residues and con-
ity, while the others (including D-His) possessed neartains three discernible domains by sequence analysis
background activity. The steady state kinetic parame-[17]. The N-terminal domain (1–80 amino acids) is sim-
ters of the PPi-ATP exchange assay were determinedilar to MbtH of the mycobactin cluster from Myco-
to be Km  100  7 M, kcat  5.8  0.5 min1 for L-His,bacterium tuberculosis, a protein with unknown func-
and Km  490  40 M, kcat  0.48  0.06 min1 fortion. The remainder of NikP1 (90-667 amino acids)
(2S,3R)-OH-His. The NikP1 A domain exhibited a 60-folddisplays significant sequence similarity to an A-PCP di-
specificity (kcat/Km) for L-His compared with -OH-His.domain NRPS module. The C-terminal PCP domain has
The substrate-dependent PPi-ATP assays validated
a conserved Ser626 surrounded by a canonical se-
that the A domain of NikP1 selectively activates L-His
quence (617DFFQVGGHSLLAA630) for posttranslational at- as L-His-AMP. The subsequent thioesterification activity
tachment of 4-phosphopantetheine (Ppant) group to of the A domain was investigated by incubations where
become a holo protein. We used a versatile PPTase, [3 H]-L-His and ATP were incubated with holo-NikP1 en-
Sfp, for phosphopantetheinylation of the NikP1 apo PCP zyme. The covalent transfer of L-His to the PCP domain
domain [18]. Time-dependent covalent attachment of is evidenced by the autoradiogram shown in Figure 4B,
[3 H]-Ppant to form holo NikP1 was observed by trichlo- while Figure 4A shows the corresponding SDS-PAGE
roacetic acid (TCA) precipitation assays using [3 H]CoA stained by Coomassie brilliant blue. Without pretreat-
as substrate (data not shown). The stoichiometry of ment with Sfp, a much weaker radioactive band was
Ppant incorporation was estimated to be 50%. NikP1 observed, indicating that E. coli-produced NikP1 was
protein coexpressed with Sfp was presumably modified largely in apo form when not coexpressed in vivo with
in vivo and was used directly without in vitro modification. Sfp. This result also implies that L-His loading was spe-
The A domains of nonribosomal peptide synthetases cific to the Ppant arm in the PCP domain. The time
are bifunctional catalysts for both aminoacyl-AMP for- dependence of NikP1 aminoacylation was measured by
mation and subsequent loading of the activated amino TCA precipitation assays. The aminoacyl-S-NikP1 spe-
acid to the free thiol of the Ppant group on the cognate cies accumulated up to a stoichiometry of 45% within
PCP domain. Detailed analysis of the amino acid se- 30 min under the conditions used in this report (data
not shown).quence of the NikP1 A domain revealed that it contained
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Figure 4. Self-Aminoacylation of NikP1 with [3 H]L-His
(A) Coomassie brilliant blue-stained 10% SDS-PAGE gel of various NikP1 samples. Lane 1, molecular weight marker; lane 2, control reaction
without pretreatment with the PPTase Sfp; lane 3, control reaction without adding ATP; lane 4, complete reaction containing holo NikP1, ATP,
[3 H]L-His, and Mg2	.
(B) Autoradiogram of the gel in (A).
Characterization of NikQ as a Heme Hydroxylase site Ser residue in the GxSxG motif and also the critical
for the Formation of -OH-L-Histidinyl-S-NikP1 His residue essential for catalytic activity [23, 24]. In the
NikQ was isolated as a red heme protein when the cul- NikP1/Q/P2 incubation, -OH-His was detected in the
ture medium was supplemented with -aminolevulinic supernatant of the reaction mixture (Figure 6, trace C),
acid and ferric iron (FeCl3). NikQ was incubated with while there was no detectable product signal in the su-
L-His-S-NikP1 to determine if it can function as a heme pernatant of the control reactions where NikP2 (Figure
hydroxylase in the formation of -OH-L-His-S-NikP1. 6, trace B) or ferredoxin reductase was omitted (Figure 6,
For all heme monooxygenases, the organic substrate trace A). Prolonged incubation generated no detectable
donates two electrons; two additional electrons are pro- -OH-His in the supernatant of a control reaction lacking
vided by the cosubstrate NADPH, mediated by two dedi- NikP2, implying that the -OH-His-S-NikP1 thioester
cated electron transfer proteins, ferredoxin and ferre- linkage is stable and the release of the product was
doxin reductase. The cognate electron transferring effected by NikP2 and not by adventitious hydrolysis.
proteins of S. tendae Tu¨901 have yet to be identified, A time course of NikP2-catalyzed release of -OH-His
so the commercially available spinach ferredoxin and was recorded, showing that the -OH-His peak grew
ferredoxin reductase were used instead. By analogy to linearly with time in the first 100 min, with over 30 turn-
the NovH/NovI system, the hydroxylation product would overs observed for NikP2 during the incubation (Figure
be tethered to the PCP domain after the incubation com-
plicating product analysis. The small molecule product
was released from the PCP domain by KOH treatment
and analyzed by strong cation exchange (SCX) HPLC.
The retention properties of -OH-L-His and L-His on a
SCX analytical column were established using authentic
standards. When [3 H]L-His-S-NikP1 was incubated with
NikQ and other necessary components, HPLC analysis
of the KOH eluant revealed a new radioactive peak pos-
sessing an identical retention time to that of the -OH-
His standard (Figure 5, trace A versus C). Coinjection
experiments with various elution profiles confirmed the
consistent coelution of the new radioactive peak with
the -OH-His standard. Parallel control experiments,
omitting either NikQ or any component of the electron
transfer chain, failed to give a detectable product signal
(Figure 5, trace B). It should be noted that free L-His
was not a substrate for NikQ (data not shown).
Characterization of NikP2 as a Thioesterase That
Figure 5. SCX-HPLC Analysis of the KOH-Released Small MoleculeReleases -OH-Histidine from NikP1 Product from the PCP Domain of NikP1 in a NikQ Catalyzed Reaction
The NikP2 protein exhibits sequence homology to type
Trace A, KOH-released materials from the L-His-S-NikP1/NikQ incu-
II TEs found in PKS and NRPS clusters. The exact role bation; trace B, control incubation lacking NikQ; trace C, chemically
these TEs play in natural product biosynthesis has yet prepared (2S,3R)-OH-His. See “Incubation of NikQ with L-His-
S-NikP1” for detailed information.to be established. NikP2 contains the conserved active
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Figure 6. SCX-HPLC Analysis of the Super-
natant of a NikP1, NikQ, and NikP2 Catalyzed
Reaction
Trace A, control incubation omitting ferre-
doxin reductase; trace B, control incubation
omitting NikP2; trace C, full NikP1/NikQ/
NikP2 reaction; trace D, standards of L-His
and (2S,3R)-OH-His. See “NikP2 Incubation
and Hydrolysis Time Course” for detailed in-
formation.
7B). A kobs of 0.14 min1 was calculated from the linear ditions in the absence of NikP2 (Figure 8, traces A and
B). Without ATP, loading of [3H]L-His was not observedpart of the time course (Figure 7A).
(Figure 8, trace E).
In Vitro Selectivity of NikP2
To assess the selectivity of NikP2 toward different Characterization of the NikP1/Q/P2
Reaction Productaminoacyl groups presented by NikP1, time courses of
the NikP2-catalyzed hydrolysis of [3 H]His-S-NikP1 and A large-scale incubation of NikP1/Q/P2 allowed isolation
of enough -OH-His product for mass characterization.[3 H]-OH-His-S-NikP1 were recorded (Figure 8). ATPase
was added prior to the addition of NikP2 to remove The product was separated by an isocratic elution (25
mM ammonium formate [pH 3.5]) on SCX-HPLC, lyophi-excess ATP and prevent the reloading of L-His by the
A domain of NikP1. NikP2 effectively hydrolyzed both lized, and subjected to MALDI-TOF MS analysis. The
measured mass of 172.0 (M 	 H	 mode) matched wellL-His and -OH-His from the PCP domain of NikP1 in
a time-dependent manner, although NikP2 exhibited a with the predicted value of -OH-His (C6H9N3O3, calcu-
lated 171.1).modest (2 fold) selectivity for -OH-His-S-NikP1 (Fig-
ure 8, trace C versus trace D). The hydrolytic process Although the newly generated chiral -hydroxy center
will be lost later in imidazolone biosynthesis (Figure 2B),for both substrates was almost complete within 10 min.
Both [3H]His-S-NikP1 and [3H]-OH-His-S-NikP1 spe- it is still of interest to examine if the hydroxylation reac-
tion effected by NikQ is stereospecific and to establishcies were kinetically stable under the experimental con-
Figure 7. Time Course of NikP2-Catalyzed (2S,3R)-OH-His Released from NikP1
(A) Plot of the product released by NikP2 over time calculated from the HPLC analysis.
(B) Stack of SCX-HPLC traces of each time points.
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Figure 8. Time Course of NikP2-Catalyzed
Aminoacyl-S-NikP1 Hydrolysis Analyzed by
TCA Precipitation Assay
ATPase was added to the reaction mixture
prior to the addition of NikP2 to remove the
excess ATP and thus prevent L-His reloading
by the A domain of NikP1. Trace A, control
reaction not including NikP2; trace B, control
reaction omitting NikQ and NikP2; trace C,
release of L-His from NikP1 in the incubation
omitting NikQ; trace D, release of -OH-His
from NikP1 by NikP2 in the full incubation;
trace E, control incubation omitting ATP.
the absolute stereochemistry of the product. As shown ing experiments established that the imidazolone base
was derived from L-His, presumably via a -OH-His in-in Figure 9, the SXC-HPLC-purified [3 H]-OH-His had
an identical retention time and peak shape as the chemi- termediate. In this report, an enzymatic route for the
formation of -OH-His used in the biosynthesis of imida-cally prepared (2S,3R)-3-OH-His (trace A versus trace
B) when analyzed by chiral HPLC (Daicel ChiralPAK WH). zolone in nikkomycins was proven to involve a free-
standing didomain NRPS module (NikP1), a heme hy-Thus, NikQ is, in fact, stereospecific and generates an
R chiral center of the -carbon. Although the (2S,3S)-3- droxylase (NikQ), and a type II thioesterase (NikP2).
NikP1 specifically activates L-His as L-His-AMP andOH-His standard is not available for chiral HPLC analy-
sis, it was unlikely that the 3R- and the 3S-diastereomer then thioesterifies it to the terminal thiol of the Ppant
prosthetic group of the holo PCP domain (Figure 2B).of -OH-His would coelute, as the coelution of the enzy-
matic product with (2S,3R)-3-OH-His was always main- The apo-PCP domain of NikP1 can be primed in vitro
with the Ppant group by the versatile PPTase Sfp ortained under various HPLC conditions when control
compounds D/L His and D/L Tyr were adequately re- in vivo by coexpression with an sfp gene-containing
plasmid [18]. The transfer of the L-His-AMP to the holo-solved (data not shown). In conjunction with the fact
that -pro-S proton of L-His was stereospecifically re- PCP domain was detected by SDS-PAGE/autoradiogra-
phy and by TCA protein precipitation assays that detecttained in the radiolabeled precursor feeding experi-
ments [4], -hydroxylation of L-His catalyzed by NikQ and quantify the stoichiometry of L-His loading.
proceeds with retention of configuration to produce NikQ recognized L-His presented by NikP1 as an
(2S,3R)-3-OH-His. aminoacyl-S-enzyme and functioned as a-hydroxylase
with regio- and stereospecificity. NikQ could not hydrox-
ylate free L-His, demonstrating that the A-PCP proteinDiscussion
scaffold is critical for substrate recognition. NikQ func-
tioned catalytically on the L-His-S-NikP1 substrate (dataNikkomycins X/I, peptidyl nucleoside antibiotics pro-
not shown) and the -hydroxylated product remainedduced by S. tendae Tu¨901, are potent competitive inhibi-
covalently linked to the PCP domain of NikP1. KOHtors of chitin synthase [1–3]. These natural products
was used to cleave the thioester linkage, releasing thecontain an aminohexuronic acid residue with an N-gly-
hydroxylated product whose identity was establishedcosidically linked 4-formyl-4-imidazolin-2-one (imidazo-
lone) base (Figure 1). Early radiolabeled precursor feed- to be (2S,3R)-3-OH-His by HPLC and by MALDI-TOF
Figure 9. Determination of the Stereochem-
istry of the Newly Generated -Center Intro-
duced by NikQ Using Chiral HPLC with a
ChiralPAK WH Analytical Column
(A) UV-HPLC trace of the (2S,3R)-OH-His
standard.
(B) Radio-HPLC trace of the NikP1/Q/P2 en-
zymatic product.
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analysis. While further C-2 hydroxylation on the imida- ment of NikP1 in nikkomycin peptide bond formation
in addition to its role in imidazolone biosynthesis. Thezole ring and removal of a two-carbon unit are required
to afford the imidazolone base (Figure 2B), we did not presence of a small domain (1–80 amino acids) on the
N terminus of NikP1 is intriguing. Similar MbtH homologyobserve a second hydroxylation reaction catalyzed by
NikQ under the assay conditions specified in this report. can be found in many other NRPS systems, such as
ORF6 in the chloroeremomycin cluster from Amycola-It remains to be seen whether an additional hydroxylase
exists for the C-2 oxygenation. topsis orientalis [11], CumB in the novobiocin cluster
from S. tendae Tu¨90 [13], ORFX in the calcium-depen-Many PKSs and NRPSs contain a terminal TE domain
(type I) for the release of the fully processed polyketide dent antibiotic (CDA) cluster of Streptomyces coelicolor
and ORF13 in the bleomycin cluster [21]. The functionor polypeptide chain, either in linear or cyclized form
depending on the nature of the TE [25, 26]. While the of these small proteins in nonribosomal peptide biosyn-
thesis is not clear, but this region of NikP1 may berole of the integrated type I TE has been clearly estab-
lished as a chain releasing agent, the function of the important for coordinating all the necessary compo-
nents for the conversion of nikkomycins Cz/CX to nikko-type II TE, which is presented in many PKS and NRPS
clusters as a free-standing identity, remains controver- mycins Z/X (Figure 1), presumably through protein–
protein interactions.sial. Deletion of type II TEs from various clusters ad-
versely affects the in vivo level of metabolite production, The adenylation, condensation (C), and carrier protein
domains reconstitute the core elements in modules ofand it has been proposed that type II TEs may play an
editing or gate-keeping role during PKS/NRPS assembly the nonribosomal peptide synthetase assembly line [15,
16, 26]. For each amino acid monomer incorporatedby removing aberrant intermediates, thus keeping the
assembly line unblocked [27, 28]. When NikP2, which is into a nonribosomal peptide, there is a corresponding
module in the NPRS gene cluster. The order and numbersimilar to type II TE proteins, was disrupted in S. tendae
Tu¨901, the mutant strain failed to produce nikkomycins of the modules dictate the sequence and the length
of the polypeptide. The initiation modules are typicallyX/I (which contain the -OH-His-derived imidazolone
base). Notably, the NikP2 disruption did not affect pro- A-PCP didomains, which are sufficient to activate and
load the starter unit, while all other modules have anduction of the uracil base containing nikkomycins Z/J
[17], suggesting a role for NikP2 in imidazolone biosyn- additional condensation domain to reconstitute the
C-A-PCP minimal assemblage for extension and termi-thesis. In this report, we clearly establish that NikP2
functions as a hydrolytic thioesterase to release the nation. The C domain is an amide bond formation cata-
lyst that adds a new amino acid monomer to the growing(2S,3R)-OH-His from the PCP domain of NikP1. In a
metabolic economic sense, it would be beneficial for polypeptide chain. In our studies of the novobiocin bio-
synthetic pathway, we recently discovered that the A-PCPthe host bacteria to have a highly selective NikP2, but
NikP2 failed to exhibit substantial selectivity for -OH-His didomain can be utilized for amino acid sequestration
in the biosynthesis of -hydroxy amino acid, and theover His in the in vitro assay. Whether NikP2 exhibits
higher selectivity in vivo or how such selectivity can be results obtained in this report generalize this proposition
[14]. In vancomycin group antibiotics, a similar set ofachieved remains to be elucidated. Potentially, selectiv-
ity can be achieved by controlling the relative concentra- proteins, ORF19 (A-PCP), ORF20 (heme protein), and
ORF19 (thioesterase), exist for the biosynthesis of-OH-tions of these three proteins, even though it was shown
that nikP1, nikP2, and nikQ are cotranscribed genes [17]. Tyr for incorporation into positions 2 and 6 of the linear
peptide [11]. Other -hydroxy amino acids, found in vari-Other possible means to achieve in vivo selectivity, e.g.,
by having a highly efficient NikQ (to keep L-His-NikP1 at ous antibiotics, may also be synthesized using this mo-
lecular logic [29]. Cytochrome P450-type heme proteina very low concentration) or by sequestering the L-His-
NikP1 species with a coordinated interaction of NikP1 monooxygenases, and possibly nonheme iron oxy-
genases, have coevolved with NRPSs to recognize theand NikQ proteins, could be envisioned. Nonetheless,
NikP2, unlike other free-standing type II TEs, clearly aminoacyl thioester presented by the specific carrier
protein domain scaffold, resulting in the -hydroxylationhas an essential function as a hydrolytic thioesterase in
-OH-His biosynthesis. of a specific fraction of the proteinogenic amino acid
pool [29]. The -hydroxy amino acid moiety can be sub-Previous studies have indicated that nikP2 and nikQ
disruption mutants produced nikkomycins Z/J, which jected to further transformations and eventual incorpo-
contain a uracil base, at the same level as the wild-type ration into the natural product or can be hydrolyzed and
strain [17]. While the nikQ disruption mutant failed to utilized as a free acid by a downstream NRPS assembly
produce any detectable nikkomycins X/I (which have line [29]. The strategy of covalent docking of a natural
the L-His-derived imidazolone base), the nikP2 mutant amino acid in a kinetically stable thioester linkage on a
produced about 2% of the wild-type level [17], indicating carrier protein could be a general practice for tailoring
that adventitious hydrolysis of the -OH-His from the the particular amino acid by hydroxylation [14], epimeri-
PCP domain of NikP1 occurred in the absence of the zation [30, 31], desaturation [32], or some other modifi-
thioesterase NikP2. Unlike the nikP2 and nikQ disruption cation prior to incorporation as a building block for the
mutants, the nikP1 mutant could not produce the uracil assembly of a secondary metabolite.
containing nikkomycins Z/J, yielding only the uncoupled
intermediate nikkomycin Cz (Figure 1) [17]. Since the
Significanceconsecutive nikP1, nikP2, and nikQ genes in the -OH-
His pathway are polycistronic (Figure 2A), single gene
Nikkomycins X/Z are potent antifungal antibiotics con-disruption mutants should give a similar phenotype. The
abnormal disruption results strongly suggest the involve- taining an unusual 4-formyl-4-imidazolin-2-one (imi-
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step gradient washes with increasing imidazole concentration (10,dazolone) base derived from L-His. This report estab-
20, 40, 60 mM imidazole) and eluted with 200 mM imidazole. Frac-lishes the roles played by three enzymes in the
tions from the washes and elution were analyzed by SDS-PAGE,biosynthetic pathway to (2S,3R)3-OH-His, a key inter-
and those containing the target protein with desired purity were
mediate for imidazolone formation. The first step in- pooled, dialyzed against a buffer (25 mM Tris [pH 7.5], 50 mM NaCl,
volves NikP1, an A-PCP didomain NRPS that selects, 1 mM DTT, and 10% glycerol), concentrated, flash frozen in liquid
nitrogen, and stored at 80C. The purity of NikP2 was not satisfac-activates, and tethers L-His to the PCP domain. The
tory and it was further purified with a Resource Q (Pharmacia) anionheme-dependent hydroxylase NikQ can then recog-
exchange column and proteins was eluted with a linear gradient ofnize the sequestered L-His and perform a -hydrox-
0-1 M NaCl in 25 mM Tris (pH 8.0). Fractions containing protein wereylation reaction in a regio- and stereospecific manner
pooled, concentrated, flash frozen in liquid nitrogen, and stored at
in the presence of molecular oxygen and two external –80C. The concentration of the purified protein was determined by
electrons. In the third step, -OH-His is hydrolytically Bradford assay.
released from NikP1 by the type II thioesterase NikP2.
This molecular logic, in which an A-PCP NRPS is uti- Priming of the PCP Domain of NikP1 with Sfp
lized to tether a proteinogenic amino acid as amino- NikP1 was isolated as an apo protein from E. coli when overex-
pressed in the absence of the sfp plasmid. The PCP domain wasacyl-S-enzyme for modification by tailoring enzymes,
modified posttranslationally with the phosphopantetheinyl groupcould represent a general strategy to sequester, and
using purified Sfp. A TCA precipitation assay was adopted to mea-thus divert, a fraction of proteinogenic amino acid to
sure the time course and the stoichiometry of the apo to holo conver-provide building blocks for the construction of sec- sion of NikP1 using free [3 H]CoA. Reactions (200 l) contained 75
ondary metabolites. mM Tris (pH 7.5), 10 mM MgCl2, 5 mM tris-(2-carboxyethylphosphine
(TCEP, Sigma), 50 M [3 H]CoA (74 Ci/mol, DuPont NEN), 4.2 M
Experimental Procedures NikP1, and 0.3 M of Sfp. Samples of 15 l were withdrawn at
various time points and quenched with 0.5 ml of 10% TCA. The
Cloning, Expression, and Purification of NikP1, NikQ, precipitated proteins were pelleted, washed with 10% TCA, redis-
and NikP2 solved in 0.5 ml of 88% formic acid, and submitted for liquid scintilla-
The nikP1, nikQ, and nikP2 genes of nikkomycin cluster were individ- tion counting. Percent modification of NikP1 was calculated from
ually amplified from S. tendae Tu¨901 (ATCC31160) genomic DNA the specific activity of the [3 H]CoA and the protein concentration.
by polymerase chain reaction (PCR). Primers NikP1-NtermNdeI Cold CoA was used for preparative priming of the NikP1 required
(5-CCAAA CAT ATG GTC AAC CCG ATT CAT GAC GAC AAC-3) by other studies. When coexpressed with Sfp, NikP1 was isolated
and NikP1-CtermXhoI (5-GGTTT CTC GAG GCT ACG TCC AGC as holo protein from E. coli, so in vitro priming with CoA by Sfp
GCG GGC CGC CGC-3) were used to amplify the nikP1 gene. The could be eliminated.
nikQ gene was amplified with primers NikQ-CtermNdeI (5-CCC TTT
CAT ATG CGC GTT GAC CTG TCC GAC CC-3) and NikQ-NtermXhoI
ATP-[32P]PPi Exchange Assay for A Domain Activity(5-GGG TTA CTC GAG TCA GGC CCT CGG GAC GAA TTT-3), while
Reactions (300 L) contained 75 mM Tris (pH 7.5), 10 mM MgCl2, 5 mMthe nikP2 gene was amplified together with nikQ gene using primers
TCEP, 2 mM ATP, 1 M NikP1, and 1 mM [32P]-pyrophosphate (3.2NikP2-NtermNdeI (5-GGG TTT CAT ATG GCA CCG CGT CAG GCT
Ci/mol). Reactions were initiated by addition of NikP1 and allowed toGCC GCC-3) and NikQ-CtermXhoI. The introduced restriction site
proceed at 24C. Aliquots (50 L) were withdrawn at various timeon each primer is underscored. The PCR products were purified,
points and quenched by the addition of a charcoal suspension (0.5 mldigested with NdeI and XhoI restriction enzymes, and ligated to
of 1.6% [w/v] activated charcoal, 4.5% [w/v] tetrasodium pyrophos-pET22b, pET28b, and pET16b vector to give C-terminally His6-
phate, and 3.5% perchloric acid in water). The charcoal was pelletedtagged NikP1, N-terminally His6-tagged NikP2, and N-terminally
by centrifugation, washed twice with quenching buffer lacking char-His10-tagged NikQ constructs, respectively. The resulting plasmids
coal, resuspended in water (1 mL), and subjected to liquid scintilla-were transformed into E. coli BL21(DE3) for protein overexpression.
tion counting. The amount of radioactivity was converted to reaction
rate by using the specific activity of the pyrophosphate. KineticProduction and Purification of NikP1, NikP2,
parameters of L-His were determined by carrying out reactions un-and NikQ Proteins
der the conditions described above, with the exception that theCells harboring the NikP1 plasmid were grown in LB medium supple-
concentration of L-His was varied. Kinetic parameters of (2S,3R)-mented with 100 g/mL ampicillin. Culture was grown at 37C until
3-OH-His were determined from reactions containing 2 M NikP1.OD600 reached 0.5, at which point temperature was lowered to 25C,
50 M of IPTG was added to induce protein production, and cell
culturing was continued for 4 hr before harvesting. To generate Aminoacylation of L-His on the PCP Domain of NikP1
To examine the second activity of the A domain, e.g., the covalentphophopantetheinylated NikP1 protein, BL21(DE3) competent cells
were cotransformed with nikP1 construct and a plasmid containing transfer of activated L-His-AMP to the terminal free thiol of panteth-
eine arm on the PCP domain of NikP1, a radio autographic studythe sfp gene. Cells were grown in LB medium in the presence of
ampicillin and chloramphenicol. Cells were grown at 25C to an was performed. Loading of NikP1 with [3 H]L-His was established
by analyzing the reaction by electrophoresis on a 10% SDS-PAGEOD600 of 0.6, at which time the temperature was lowered to 15C,
the cells induced with 60 M IPTG and allowed to grow for an gel. Control reactions, in which either Sfp or ATP was removed, were
carried out and analyzed on the same gel. After electrophoresis, theadditional 18 hr. An overnight culture of NikQ (10 mL) was used to
inoculate 1L LB medium (100 g/ml ampicillin, 50 mg/L FeCl3, 50 gel was stained with Coomassie brilliant blue, destained, and
soaked in Amplify (Amersham) for 15 min. The dried gel was exposedmg/L -aminolevulinic acid) and the culture was allowed to grow at
15C for 72 hr without adding IPTG for induction. Cells containing to a Biomar blue sensitive film (Marsh) for 36 hr at 80C before
developing. TCA precipitation assays were used to quantify theNikP2 plasmid were cultured under same conditions as that of NikP1
overexpressed alone. A general procedure of Ni-NTA affinity chro- stoichiometry of auto aminoacylation of L-His by NikP1. Reactions
were performed at 24C in 100 l volumes containing 75 mM Trismatography was used to purify all three proteins. Cells were har-
vested by centrifugation, resuspended in binding buffer (25 mM Tris (pH 7.5), 10 mM MgCl2, 5 mM TCEP, 3.3 M NikP1, 5 mM [3 H]L-His
(5.3 Ci/mol), and 3 mM ATP. Aliquots of 10 l were withdrawn at[pH 8.0], 400 mM NaCl, and 5 mM imidazole), and lysed by French
Press (two passages at 15000 psi); cellular debris was removed by various time points and quenched with 0.5 ml of 10% TCA in the
presence of 10l of the carrier protein BSA (10 mg/mL). The precipi-centrifugation (30 min at 15,000 g). Supernatant was incubated with
3 ml nickel NTA resin (Pharmacia) and allowed to bind in batch for tated proteins were pelleted, washed, and counted for radioactivity.
Percentage of loading was calculated from the specific activity of2 hr. The resin was decanted into a column and washed with 15
bed volumes of binding buffer. Protein elution was achieved by a [3 H]L-His and the concentration of NikP1.
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Incubation of NikQ with L-His-S-NikP1 After proteins were removed by filtration with a Centricon 10 (Ami-
con), the -OH-His product was isolated by SCX-HPLC using anA reaction mixture (250 l) containing 75 mM Tris (pH 7.5), 10 mM
MgCl2, 0.2 mM [3 H]L-His (72 Ci/mol), 3 mM ATP, 2 mM TCEP, and isocratic elution with 50 mM ammonium formate (pH 3.5). Repeated
cycles of lyophilization removed the majority of the buffer salt, and30 M holo NikP1 was incubated at 24C to load L-His onto the PCP
domain of NikP1. After 2 hr of incubation, NADPH (2mM), spinach the solid residue was subjected to MALDI-TOF analysis. Similarly,
[3 H]--OH-His was enzymatically synthesized using the procedureferredoxin (5 M), ferredoxin reductase (0.1 unit), and NikQ (2.5 M)
were added to the above incubation mixture to a final volume of described in the previous section and isolated by ammonium for-
mate elution on SCX-HPLC. After lyophilization, the cold reference300 l. The reaction was quenched with 0.5 ml 10% TCA after
two additional hours of incubation. The precipitated proteins were compound (2S,3R)-3-OH-His was mixed with the purified [3 H]--OH-
His and the stereochemistry of the  center was established bypelleted by centrifugation, washed twice with 0.5 ml 10% TCA, and
redissolved in 100 l of 0.1 N KOH solution. The enzymatic product chiral HPLC analysis with a ChiralPAK WH column (Daicel). Isocratic
elution of 4.0 mM CuSO4 was used at a flow rate of 1 mL/min. Thewas released from the carrier protein by incubating for 10 min at
60C. Routinely, a small amount of authentic (2S,3R)--OH-L-His UV absorbance (at 220 nm) and radioactivity detectors were used
to monitor the retention times of the cold reference compound andwas added in the workup as a nonlabeled carrier compound. The
proteins were precipitated by acidifying the mixture with 5 l of the hot NikP1Q/P2 enzymatic product, respectively.
50% TFA and removed by centrifugation. New product formation
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